Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1490343
European Journal of Endocrinology, Vol 149, Issue 4, 343-350
Copyright © 2003 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peterhoff, M
Right arrow Articles by Ullrich, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peterhoff, M
Right arrow Articles by Ullrich, S

Articles

Inhibition of insulin secretion via distinct signaling pathways in alpha2-adrenoceptor knockout mice

M Peterhoff, A Sieg, M Brede, CM Chao, L Hein, and S Ullrich

Institute of Neurophysiology, University of Cologne, Robert Koch Strasse 39, D-50931 Cologne, Germany.

OBJECTIVE: Adrenaline inhibits insulin secretion through activation of alpha(2)-adrenoceptors (ARs). These receptors are linked to pertussis toxin-sensitive G proteins. Agonist binding leads to inhibition of adenylyl cyclase, inhibition of Ca(2+) channels and activation of K(+) channels. Recently, three distinct subtypes of alpha(2)-AR were described, alpha(2A)-AR, alpha(2B)-AR and alpha(2C)-AR. At present, it is unknown which of these alpha(2)-AR subtype(s) may regulate insulin secretion. We used mice deficient in alpha(2)-ARs to analyze the coupling and role of individual alpha(2)-AR subtypes in insulin-secreting beta cells. METHODS: The inhibitory effect of adrenaline on insulin secretion was measured in freshly isolated and cultured wild type (wt) and alpha(2)-AR knockout (KO) mouse islets in order to examine the receptor subtypes which mediate adrenaline-induced inhibition of insulin secretion. Adenylyl cyclase activity was measured in isolated cultured islets. Membrane potential was measured using the amphotericin B permeabilized patch clamp method in isolated and cultured single islet cells. RESULTS: In wt, alpha(2A)- and alpha(2C)-AR KO mouse islets, adrenaline, 1 microM/L, inhibited secretion by 83, 80 and 100% respectively. In contrast, in alpha(2A/2C)-AR double KO mouse islets, adrenaline had no effect on stimulated secretion indicating that both alpha(2A)-AR and alpha(2C)-AR, but not alpha(2B)-AR, are functionally expressed in mouse islets. Surprisingly, glucose (16.7 mM/L)-induced secretion in the presence of 1 microM/L forskolin was greatly impaired in alpha(2A)-AR KO islets. However, when cAMP levels were increased further by the combination of forskolin (5 microM/L) and 3-isobutyl-1-methylxanthine (100 microM/L), secretion was stimulated 2.7-fold (8.5-fold in wt islets). Adrenaline lowered the concentration of cAMP in wt and alpha(2C)-AR KO mouse islets by 74%. Adrenaline also hyperpolarized wt and alpha(2C)-AR KO beta cells. In contrast, adrenaline did not inhibit adenylyl cyclase in islets of alpha(2A)-AR KO mice, nor did it hyperpolarize alpha(2A)-AR KO beta cells. CONCLUSION: Adrenaline inhibits insulin release through alpha(2A)- and alpha(2C)-ARs via distinct intracellular signaling pathways.


This article has been cited by other articles:


Home page
EndocrinologyHome page
M. Kobayashi, H. Ohnishi, H. Okazawa, Y. Murata, Y. Hayashi, H. Kobayashi, T. Kitamura, and T. Matozaki
Expression of Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 in Pancreatic {beta}-Cells and Its Role in Promotion of Insulin Secretion and Protection against Diabetes
Endocrinology, November 1, 2008; 149(11): 5662 - 5669.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C.-J. Dong, Y. Guo, P. Agey, L. Wheeler, and W. A. Hare
{alpha}2 Adrenergic Modulation of NMDA Receptor Function as a Major Mechanism of RGC Protection in Experimental Glaucoma and Retinal Excitotoxicity
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4515 - 4522.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
Weizhen Wu, Jin Shang, Yue Feng, C. M. Thompson, S. Horwitz, J. R. Thompson, E. D. Macintyre, N. A. Thornberry, K. Chapman, Y.-P. Zhou, et al.
Identification of Glucose-Dependent Insulin Secretion Targets in Pancreatic {beta} Cells by Combining Defined-Mechanism Compound Library Screening and siRNA Gene Silencing
J Biomol Screen, February 1, 2008; 13(2): 128 - 134.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. A. Bavadekar, G. Ma, S. M. Mustafa, B. M. Moore, D. D. Miller, and D. R. Feller
Tethered Yohimbine Analogs as Selective Human {alpha}2C-Adrenergic Receptor Ligands
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 739 - 748.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
X. Hu, D. Friedman, S. Hill, R. Caprioli, W. Nicholson, A. C Powers, L. Hunter, and L. E Limbird
Proteomic exploration of pancreatic islets in mice null for the {alpha}2A adrenergic receptor
J. Mol. Endocrinol., August 1, 2005; 35(1): 73 - 88.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 European Society of Endocrinology.